250 related articles for article (PubMed ID: 36035176)
21. Identification of Breast Cancer Immune-related Prognostic Characteristics in Tumor Microenvironment.
Tang Z; Li L; Huang X; Zhao Y; Liu Q; Zhang C
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38213151
[TBL] [Abstract][Full Text] [Related]
22. Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer.
Geng QS; Huang T; Li LF; Shen ZB; Xue WH; Zhao J
Front Med (Lausanne); 2021; 8():812278. PubMed ID: 35141255
[TBL] [Abstract][Full Text] [Related]
23. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
24. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
Ling J; Peng N; Luo L
J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
[TBL] [Abstract][Full Text] [Related]
25. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
[TBL] [Abstract][Full Text] [Related]
26. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma.
Xiao X; Shan H; Niu Y; Wang P; Li D; Zhang Y; Wang J; Wu Y; Jiang H
Front Mol Biosci; 2022; 9():647826. PubMed ID: 35558557
[TBL] [Abstract][Full Text] [Related]
27. CCDC134 as a Prognostic-Related Biomarker in Breast Cancer Correlating With Immune Infiltrates.
Huang Z; Yang L; Chen J; Li S; Huang J; Chen Y; Liu J; Wang H; Yu H
Front Oncol; 2022; 12():858487. PubMed ID: 35311121
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor.
Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA
Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626
[TBL] [Abstract][Full Text] [Related]
29. Effect of caspase-1 (
Peng J; Wei Q; Zhou S; Gu Z; Lv K
Transl Cancer Res; 2023 Aug; 12(8):2138-2154. PubMed ID: 37701103
[TBL] [Abstract][Full Text] [Related]
30. Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer.
Qin M; Ma Y; Wang Z; Fang D; Wei J
Transl Cancer Res; 2021 Jun; 10(6):2991-3003. PubMed ID: 35116607
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
32. UBE2C as an Immune-Related Biomarker for Breast Cancer: A Study Based on Multiple Databases.
Cui Y; Wang HZ; Song Y; Yang S; Sai FY; Yu DJ
Chin Med Sci J; 2024 May; ():. PubMed ID: 38828693
[TBL] [Abstract][Full Text] [Related]
33. PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer.
Chen Z; Zhong S; Zhang Z; Tang J
Biochem Genet; 2023 Aug; 61(4):1369-1386. PubMed ID: 36598702
[TBL] [Abstract][Full Text] [Related]
34. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
35. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
36. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
37. Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma.
Zhong P; Shu R; Wu H; Liu Z; Shen X; Hu Y
Exp Ther Med; 2021 Apr; 21(4):305. PubMed ID: 33717248
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration.
Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G
Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330
[No Abstract] [Full Text] [Related]
39. An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer.
Jiang H; Sun J; Liu F; Wu X; Wen Z
Front Genet; 2022; 13():895200. PubMed ID: 35812755
[No Abstract] [Full Text] [Related]
40. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
